105
Views
10
CrossRef citations to date
0
Altmetric
Articles

The role of estrogen receptors, erbB receptors, vascular endothelial growth factor and its receptors, and vascular endothelial growth inhibitor in the development of the rat mammary gland

&
Pages 379-393 | Received 11 Feb 2010, Accepted 20 May 2010, Published online: 24 Jun 2010

References

  • Bates DO, Hillman NJ, Williams B, Neal CR, Pocock TM. 2002. Regulation of microvascular permeability by vascular endothelial growth factors. J Anat. 200:581–597.
  • Brisken C, Park S, Vass T, Lydon CP, O'Malley BWO. 1998. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci USA. 95:5076–5081.
  • Chew LJ, Pan H, Yu J, Tian S, Huang W-Q, Zhang JY, Pang S, Li L-Y. 2002. A novel secreted splice variant of vascular endothelial cell growth inhibitor. FASEB J. 16:742–744.
  • Ciarloni L, Mallepell S, Brisken C. 2007. Amphiregulin is an essential mediator of estrogen receptor a function in mammary gland development. Proc Natl Acad Sci USA. 10:45455–45460.
  • Connor EE, Meyer MJ, Li RW, Van Amburgh ME, Boisclair YR, Capuco AV. 2007. Regulation of gene expression in the bovine mammary gland by ovarian steroids. J Dairy Sci. 90:55–65.
  • Cunha GR. 1994. Role of mesenchymal-epithelial ınteractions in normal and abnormal development of the mammary gland and prostate. Breast Cancer Res. 74:1030–1044.
  • Dallard BE, Ruffino V, Heffel S, Calvinho LF. 2006. Effect of a biological response modifier on expression of growth factors and cellular proliferation at drying off. J Dairy Sci. 90:2229–2240.
  • Darcy KM, Zangani D, Wohlhueter AL, Huang R-Y, Vaughan MM, Russell JA, Ip MM. 2000. Changes in ErbB2 (her-2/neu), ErbB3, and ErbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cells. J Histochem Cytochem. 48:63–80.
  • Detre S, Saccani JS, Dowsett M. 1995. A “quickscore” method for immunohistochemical semiquantitation: Validation for estrogen receptor in breast carcinomas. J Clin Pathol. 48:876–879.
  • Dvorak HF, Brown LF, Detmar M, Dvorak AM. 1995. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 146:1029–1039.
  • Eccles SA. 2001. The Role of c-erbB-2/HER2/neu in breast cancer progression and metastasis. J Mammary Gland Biol Neoplasia. 6:393–405.
  • Edery M, Pang K, Larson L, Colosi T, Nandi S. 1985. Epidermal growth factor receptor levels in mouse mammary glands in various physiological states. Endocrinology. 117:405–411.
  • Fenton SE, Sheffield LG. 1993. Prolactin ınhibits epidermal growth factor (egf)-stimulated signaling events in mouse mammary epithelial cells by altering egf receptor function. Mol Biol Cell. 4:773–780.
  • Hovey RC, Goldhar AS, Baffi J, Vonderhaar BK. 2001. Transcriptional regulation of vascular endothelial growth factor expression in epithelial and stromal cells during mouse mammary gland development. Mol Endocrinol. 15:819–831.
  • Hunter T. 2000. Signaling. Cell. 100:113–127.
  • Hyder SM. 2006. Sex-steroid regulation of vascular endothelial growth factor in breast cancer. Endoc Relat Cancer. 13:667–687.
  • Jackson-Fisher AJ, Bellinger G, Breindel JL, Tavassoli FA, Booth CJ, Duong JK, Stern DF. 2008. ErbB3 is required for ductal morphogenesis in the mouse mammary gland. Breast Cancer Res. 10:1–12.
  • Jones FE, Stern DF. 1999. Expression of dominant-negative erbb2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation. Oncogene. 18:3481–3490.
  • Jones FE, Welte T, Fu XY, Stern DF. 1999. ErbB4 signaling in the mammary gland is required for lobuloalveolar development and stat5 activation during lactation. J Cell Biol. 147:77–87.
  • Kariagina A, Aupperlee MD, Haslam SZ. 2007. Progesterone receptor isoforms and proliferation in the rat mammary gland during development. Endocrinology. 148:2723–2736.
  • Klijn JGM, Berns PMJJ, Schmitz PIM, Foekens JA. 1992. The clinical significance of epidermal growth factor receptor (egf-r) in human breast cancer: A review on 5232 patients. Endocrine Soc. 13:1.
  • Long W, Wagner KU, Kent Loyd KC, Binart N, Shillingford JM, Hennighausen L, Jones FE. 2003. Impaired differentiation and lactational failure of erbb4-deficient mammary glands identify erbb4 as an obligate mediator of STAT5. Development. 130:5257–5268.
  • Luetteke NC, Qiu TH, Fenton SE, Troyer KL, Riedel RF, Chang A, Lee DC. 1999. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development. 126:2739–2750.
  • Masso-Welch PA, Kathleen MD, Nannette CSC, Ip MM. 2000. A developmental atlas of rat mammary gland histology. J Mammary Gland Biol. 5:165–185.
  • Matsumoto M, Nishinakagawa H, Kurohmaru M, Hayashi Y, Otsuka J. 1992. Pregnancy and lactation affect the microvasculature of the mammary gland in mice. J Vet Med Sci. 54:937–943.
  • Metheny-Barlowa LJ, Lib LY. 2006. Vascular endothelial growth ınhibitor (VEGF), an endogenous negative regulator of angiogenesis. Ophthalmology. 21:49–58.
  • Millauer B, Wizigmann-Voos S, Schnürch H, Martinez R, Moller NP, Risau W, Ullrich A. 1993. High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 72:835–846.
  • Mudduwa LKB. 2009. Quick score of hormone receptor status of breast carcinoma: Correlation with the other clinicopathological prognostic parameters. Indian J Pathol Microbiol. 52:159–163.
  • Nakamura J, Lu Q, Aberdeen G, Albrecht E, Brodie A. 1999. The effect of estrogen on aromatase and vascular endothelial growth factor messenger ribonucleic acid in the normal nonhuman primate mammary gland. J Clin Endocrinol Metab. 84:1432–1437.
  • Neuchrist C, Erovic BM, Handisurya A, Fischer MB, Steiner GE, Hollemann D, Gedlicka C, Saaristo A, Burian M. 2003. Vascular endotelial growth factor c and vascular endotelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head Neck. 25:464–474.
  • Nishimura S, Maeno N, Matsuo K, Fischer MB, Steiner GE, Hollemann D, Gedlicka C, Saaristo A, Burian M. 2002. Human lactiferous mammary gland cells produce vascular endothelial growth factor (VEGF) and express the VEGF receptors, Flt-1 and KDR/Flk-1. Cytokine. 18:191–198.
  • Pepper MS, Baetens D, Mandriota SJ, Di Sanza C, Lane TF, Soriano JV, Montesano R, Iruela-Arispe ML. 2000. Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution. Dev Dyn. 218:507–524.
  • Price-Schiavi SA, Andrechek E, Idris N, Li P, Rong M, Zhang J, Carraway CAC, Muller WJ, Carraway KL. 2005. Expression, location, and ınteractions of erbb2 and its ıntramembrane ligand Muc4 (Sialomucin Complex) in rat mammary gland during pregnancy. J Cell Physiol. 203:44–53.
  • Rajkumar T. 2001. Growth factors and growth factor receptors in cancer. Curr Sci. 81:535–541.
  • Reece WO. 2004. Physiology of domestic animals. New York, NY: Cornell University Press. p 710–711.
  • Rossiter H, Barresi C, Ghannadan M, Gruber F, Mildner M, Födinger D, Tschachler E. 2007. Inactivation of VEGF in mammary gland epithelium severely compromises mammary gland development and function. FASEB J. 21:3994–4004.
  • Salomon DS, Brandt R, Ciardiello F, Normanno N. 1995. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol. 19:183–232.
  • Salomon DS, Bianco C, Santis MD. 1999. Cripto: A novel epidermal growth factor (egf)-related peptide in mammary gland development and neoplasia. BioEssays. 21:61–70.
  • Schroeder JA, Lee DC. 1998. Dynamic expression and activation of ErbB receptors in the developing mouse mammary gland. Cell Growth Differ. 9:451–464.
  • Schroeder JA, Thompson MC, Gardner MM, Gendler SJ. 2001. Transgenic MUC1 ınteracts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. J Biol Chem. 276:13057–13064.
  • Sebastian J, Richards RG, Walker MP, Wiesen JF, Werb Z, Derynck R, Hom YK, Cunha GR, DiAugustine RP. 1998. Activation and function of the epidermal growth factor receptor and erbb-2 during mammary gland morphogenesis. Cell Growth Differ. 9:777–785.
  • Sheffield LG. 1998. Hormonal regulation of epidermal growth factor receptor content and signaling in bovine mammary tissue. Endocrine. 139:4568–4575.
  • Snedeker SM, Brown CF, Diaugustine RP. 1991. Expression and functional properties of transforming growth factora and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc Natl Acad Sci USA. 88:276–280.
  • Stern DF. 2003. ErbBs in mammary development. Exp Cell Res. 284:89–98.
  • Stern DF. 2008. ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer. J Mammary Gland Biol Neoplasia. 13:215–223.
  • Taketani Y, Oka T. Biological action of epidermal growth factor and ıts functional receptors in normal mammary epithelial cells. Proc Natl Acad Sci USA. 1983a; 80:2647–2650.
  • Taketani Y, Oka T. Possible physiological role of epidermal growth factor in the development of the mouse mammary gland during pregnancy. EIsevier Biomed. 1983b; 152:2.
  • Wada T, Qian X, Greene MI. 1990. Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function. Cell. 61:1339–1347.
  • Wiesen JF, Young P, Werb Z, Cunha GR. 1999. Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development. 126:335–344.
  • Xiao Q, Hsu CY, Chen H, Ma X, Xu J, Lee JM. 2005. Characterization of cis-regulatory elements of the vascular endothelial growth inhibitor gene promoter. Biochem J. 388:913–992.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.